Article
Multidisciplinary Sciences
Katja J. Jarick, Patrycja M. Topczewska, Manuel O. Jakob, Hiroshi Yano, Mohammad Arifuzzaman, Xuemei Gao, Sotiria Boulekou, Vladislava Stokic-Trtica, Pierre S. Leclere, Alexandra Preusser, Zoe A. Rompe, Anton Stamm, Amy M. Tsou, Coco Chu, Frederik R. Heinrich, Gabriela M. Guerra, Pawel Durek, Andranik Ivanov, Dieter Beule, Sofia Helfrich, Claudia U. Duerr, Anja A. Kuehl, Christina Stehle, Chiara Romagnani, Mir-Farzin Mashreghi, Andreas Diefenbach, David Artis, Christoph S. N. Klose
Summary: This article investigates the role of innate lymphoid cells (ILCs) in protective immunity. Using a mouse model specific to ILCs, researchers found that ILC2s have non-redundant functions during steady state and disease, and they interact with adaptive immune cells to organize the immune system.
Article
Multidisciplinary Sciences
Jongho Ham, Jihyun Kim, Kyoung-Hee Sohn, In-Won Park, Byoung-Whui Choi, Doo Hyun Chung, Sang-Heon Cho, Hye Ryun Kang, Jae-Woo Jung, Hye Young Kim
Summary: This study found that cigarette smoking exacerbates asthma by increasing the frequencies of activated type 3 innate lymphoid cells (ILC3) in the sputum and blood of patients. These activated ILC3 cells are associated with non-allergic inflammation and increased severity of asthma.
NATURE COMMUNICATIONS
(2022)
Editorial Material
Immunology
Lisa Schmidleithner, Markus Feuerer
Summary: A recent study reveals that repression of Satb1 in CD4(+) T cells can drive intratumoral TLS formation, resulting in reduced tumor growth.
TRENDS IN IMMUNOLOGY
(2022)
Review
Immunology
Nicolas Jacquelot, Cyril Seillet, Eric Vivier, Gabrielle T. Belz
Summary: Innate lymphoid cells (ILCs) play a role in immune responses and have been found to have pleiotropic effects in various tissues, including both tissue repair and immunopathology toward allergens and promotion of tumorigenesis. Recent studies suggest that non-NK ILCs might be harnessed for anti-tumor responses. Gabrielle Belz and colleagues review the influence of ILCs on cancer immune responses.
Review
Immunology
Raquel Castillo-Gonzalez, Ana Valle-Noguera, Maria Jose Gomez-Sanchez, Pu Xia, Aranzazu Cruz-Adalia
Summary: Cancer is a complex disease caused by genetic and environmental factors. Innate lymphoid cells (ILCs), which lack antigen-specific receptors, have been found in tumors and play a role in early immune response. Among ILCs, ILC3s are controversial in tumor immunity, as they can enhance anti-tumor immunity but also promote tumor growth.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Immunology
Ebru Aydin, Sebastian Faehling, Mariam Saleh, Laura Llao Cid, Martina Seiffert, Philipp M. Roessner
Summary: PI3K pathway plays a crucial role in cell growth and malignant transformation, with its hyperactivation being a hallmark of cancer. Inhibiting PI3K not only affects cancer cells but also impacts the tumor microenvironment and immune cell function. Understanding the effects of PI3K inhibition on the tumor microenvironment in CLL can lead to improved drug development and novel combinatory treatment strategies.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Natasha M. Setiabakti, Pia Larsson, Justin R. Hamilton
Summary: Understanding the role of phosphoinositide 3-kinases (PI3Ks) in platelet function and thrombus formation is crucial for the development of therapeutic drugs for thrombotic cardiovascular diseases.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Alexandra M. Simond, Tung Bui, Dongmei Zuo, Virginie Sanguin-Gendreau, Trisha Rao, Wayne A. Phillips, Robert D. Cardiff, William J. Muller
Summary: This study found that the p110 alpha(HR) mutation attenuates metastatic behavior and is associated with the formation of ductal carcinoma in situ (DCIS) in ErbB2-driven breast cancer.
Article
Biochemistry & Molecular Biology
Sasja Blokzijl-Franke, Bas Ponsioen, Stefan Schulte-Merker, Philippe Herbomel, Karima Kissa, Suma Choorapoikayil, Jeroen den Hertog
Summary: The study found that HSPCs in mutant zebrafish embryos lacking pten function exhibited death during development, which could be rescued by inhibiting PI3K, while inhibiting PI3K in wild-type embryos also induced HSPC death. PI3K signaling tightly controls HSPC survival, with both up- and downregulation of the signaling pathway reducing stemness of HSPCs.
Article
Allergy
Jessica Oh, Elizabeth Garabedian, Ramsay Fuleihan, Charlotte Cunningham-Rundles
Summary: Activated phosphoinositide 3-kinase delta syndrome is a combined primary immunodeficiency characterized by various manifestations such as respiratory infections, lymphadenopathy, and developmental delay. Clinical features differ between PIK3CD and PIK3R1 patients, with a higher frequency of asthma observed in the PIK3CD cohort.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
(2021)
Article
Hematology
Danika Di Giacomo, Roberta La Starza, Paolo Gorello, Fabrizia Pellanera, Zeynep Kalender Atak, Kim De Keersmaecker, Valentina Pierini, Christine J. Harrison, Silvia Arniani, Martina Moretti, Nicoletta Testoni, Giovanna De Santis, Giovanni Roti, Caterina Matteucci, Renato Bassan, Peter Vandenberghe, Stein Aerts, Jan Cools, Beat Bornhauser, Jean-Pierre Bourquin, Rocco Piazza, Cristina Mecucci
Summary: The study identified a distinct subgroup of immature acute leukemias characterized by 14g32/BCL11B translocations, including AML, TIM MPAL, and ETP-ALL. These translocations activate BCL11B, whose expression behaves as a disease biomarker present at diagnosis and co-occurs with variants at FLT3 and epigenetic modulators. Transcriptome analysis revealed a specific expression signature separating BCL11B AL from AML, T-ALL, and ETP-ALL, with an ex vivo drug-sensitivity profile identifying effective antileukemic compounds.
Review
Immunology
Huiyang Yu, Nicolas Jacquelot, Gabrielle T. Belz
Summary: This article reviews the critical role of innate lymphoid cells in tissue protection and immunity in animals, and discusses their metabolic pathways and adaptability to changing conditions. Reprogramming immune cell metabolism may offer new strategies for modulating immune cell behavior and treating various diseases.
JOURNAL OF EXPERIMENTAL MEDICINE
(2022)
Article
Multidisciplinary Sciences
Ke Xu, Na Yin, Min Peng, Efstathios G. Stamatiades, Amy Shyu, Peng Li, Xian Zhang, Mytrang H. Do, Zhaoquan Wang, Kristelle J. Capistrano, Chun Chou, Andrew G. Levine, Alexander Y. Rudensky, Ming O. Li
Summary: The passage discusses the impact of infection on T cell immune response, highlighting the crucial role of glycolytic enzyme LDHA in regulating the PI3K-Akt-Foxo1 signaling pathway, a mechanism that serves as a key factor in controlling T cell immunity.
Article
Biology
Abigail Cunningham, Maddisen Brown, Jonathan Dresselhuis, Nicole Robinson, Keni Hervie, Michael E. Cox, Julia Mills
Summary: This study investigates a novel cancer drug combination strategy targeting glioblastoma cells. The results demonstrate that combination drug treatment significantly increases cell death and aberrant mitotic division, compared to individual inhibitors.
Article
Multidisciplinary Sciences
Piotr Bielecki, Samantha J. Riesenfeld, Jan-Christian Hutter, Elena Torlai Triglia, Monika S. Kowalczyk, Roberto R. Ricardo-Gonzalez, Mi Lian, Maria C. Amezcua Vesely, Lina Kroehling, Hao Xu, Michal Slyper, Christoph Muus, Leif S. Ludwig, Elena Christian, Liming Tao, Amanda J. Kedaigle, Holly R. Steach, Autumn G. York, Mathias H. Skadow, Parastou Yaghoubi, Danielle Dionne, Abigail Jarret, Heather M. McGee, Caroline B. M. Porter, Paula Licona-Limon, Will Bailis, Ruaidhri Jackson, Nicola Gagliani, Georg Gasteiger, Richard M. Locksley, Aviv Regev, Richard A. Flavell
Summary: This study reveals that induction of psoriasis in mice by IL-23 or imiquimod leads to a reconfiguration of skin ILCs towards a pathogenic ILC3-like state. Skin ILCs exhibit a range and flexibility in their responses, indicating that immune activities primed in healthy tissues dynamically adapt to provocations and, left unchecked, drive pathological remodelling.
Article
Immunology
Anne Tersteegen, Ursula R. Sorg, Richard Virgen-Slane, Marcel Helle, Patrick Petzsch, Ildiko R. Dunay, Karl Kohrer, Daniel Degrandi, Carl F. Ware, Klaus Pfeffer
Summary: LT beta receptor plays a critical role in regulating adaptive immune responses to control T. gondii infection. LT beta receptor deficiency leads to globally altered IFN-gamma regulation, absence of parasite-specific IgG response, and severe loss of immune control over the parasites.
INFECTION AND IMMUNITY
(2021)
Article
Biotechnology & Applied Microbiology
Tobias Beer, Sebastian Haensch, Klaus Pfeffer, Sander H. J. Smits, Stefanie Weidtkamp-Peters, Lutz Schmitt
Summary: Secretion systems play a vital role in Gram-negative bacteria by allowing communication with the outside world. This study focused on the hemolysin A (HlyA) type I secretion system (T1SS) in Escherichia coli and analyzed its localization and clustering. The results showed that the amount of ToIC, a component of the T1SS, was not affected by overexpression of the HlyBD complex. Superresolution microscopy revealed that the HlyA T1SS did not exhibit polarization and the size of T1SS clusters did not correlate with outer membrane islands.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY
(2022)
Review
Immunology
Marc Dalod, Stefanie Scheu
Summary: DCs play a crucial role in antigen presentation and orchestrate information transfer in the immune system. Mouse models provide valuable insights into the different functions of DC types and their activation states. This article provides comprehensive information on selecting mutant mouse strains for DC research and discusses the advantages, limitations, and future perspectives of these models.
EUROPEAN JOURNAL OF IMMUNOLOGY
(2022)
Article
Oncology
Jessica M. Salmon, Izabela Todorovski, Kym L. Stanley, Claudia Bruedigam, Conor J. Kearney, Luciano G. Martelotto, Fernando Rossello, Timothy Semple, Gisela Mir Arnau, Magnus Zethoven, Michael Bots, Stefan Bjelosevic, Leonie A. Cluse, Peter J. Fraser, Veronique Litalien, Eva Vidacs, Kate McArthur, Antony Y. Matthews, Elise Gressier, Nicole A. de Weerd, Jens Lichte, Madison J. Kelly, Simon J. Hogg, Paul J. Hertzog, Lev M. Kats, Stephin J. Vervoort, Daniel D. De Carvalho, Stefanie Scheu, Sammy Bedoui, Benjamin T. Kile, Steven W. Lane, Andrew C. Perkins, Andrew H. Wei, Pilar M. Dominguez, Ricky W. Johnstone
Summary: Inhibition of HDACs can induce differentiation and therapeutic effects in AML cells, and epigenetic rewiring of pDCs enhances antitumor immunity, offering a new therapeutic approach.
Article
Immunology
Xiaoli Yang, Shafaqat Ali, Manman Zhao, Lisa Richter, Vanessa Schaefer, Julian Schliehe-Diecks, Marian Frank, Jing Qi, Pia-Katharina Larsen, Jennifer Skerra, Heba Islam, Thorsten Wachtmeister, Christina Alter, Anfei Huang, Sanil Bhatia, Karl Koehrer, Carsten Kirschning, Heike Weighardt, Ulrich Kalinke, Rainer Kalscheuer, Markus Uhrberg, Stefanie Scheu
Summary: This study reveals that BEA activates BMDCs and induces the production of inflammatory cytokines and chemokines, which is dependent on the MyD88 and TRIF signaling pathways as well as TLR4. These findings contribute to a better understanding of the mechanism of action of BEA in immune cells.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Jean Piero Margaria, Lucia Moretta, Jose Carlos Alves-Filho, Emilio Hirsch
Summary: This article summarizes the progress in understanding the role of PI3K/Akt in the development of lung fibrosis and its causative pathological context, including sepsis as well as acute lung injury (ALI) and its consequent acute respiratory distress syndrome (ARDS). Current knowledge about PI3K inhibitors for pulmonary fibrosis treatment, including drugs under development as well as in clinical trials, is further summarized. The discussion also includes how the design of inhaled compounds targeting the PI3K pathways might potentiate efficacy and improve tolerability.
Editorial Material
Cardiac & Cardiovascular Systems
Carlo G. Tocchetti, Alessandra Ghigo, Emilio Hirsch
Summary: This editorial discusses the study conducted by Lu et al. on the protective effect of circular RNA derived from the insulin receptor locus against doxorubicin-induced cardiotoxicity.
EUROPEAN HEART JOURNAL
(2022)
Article
Biochemistry & Molecular Biology
Zhihuang Zheng, Yao Xu, Ute Krugel, Michael Schaefer, Tilman Grune, Bernd Nurnberg, May-Britt Kohler, Maik Gollasch, Dmitry Tsvetkov, Lajos Marko
Summary: The pharmacological inhibition of TRPC6 has shown promising results in ameliorating renal fibrosis and inflammation in a mouse model of metabolic syndrome. The study suggests that targeting TRPC6 could be a potential therapeutic method for treating progressive tubulo-interstitial fibrosis in hypertension and metabolic syndrome.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Clinical Neurology
Jana Freff, Eva C. Beins, Lisa Broeker, Kathrin Schwarte, Rafael Leite Dantas, Carlo Maj, Volker Arolt, Udo Dannlowski, Markus M. Noethen, Bernhard T. Baune, Andreas J. Forstner, Judith Alferink
Summary: This study characterizes the expression pattern of CCR4 and its ligands CCL17 and CCL22 in major depressive disorder (MDD) and explores their clinical relevance in predicting disease severity. The results show that decreased CCR4 expression and increased CCL17/CCL22 levels are associated with MDD. CCR4 expression on CD4(+) T cells is correlated with depression severity and specific symptoms. Additionally, CCR4 and polygenic risk score (PRS) have predictive capacity for disease severity.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Article
Immunology
Manfred B. Lutz, Shafaqat Ali, Cindy Audiger, Stella E. Autenrieth, Luciana Berod, Venetia Bigley, Laura Cyran, Marc Dalod, Jan Doerrie, Diana Dudziak, Georgina Florez-Grau, Lucila Giusiano, Gloria J. Godoy, Marion Heuer, Anne B. Krug, Christian H. K. Lehmann, Christian T. Mayer, Shalin H. Naik, Stefanie Scheu, Gerty Schreibelt, Elodie Segura, Kristin Sere, Tim Sparwasser, Jurjen Tel, Huaming Xu, Martin Zenke
Summary: This article is part of a series of guidelines on dendritic cells, providing advanced protocols for the preparation and characterization of murine and human dendritic cells. The protocols cover the preparation and generation of dendritic cells from different cellular sources, including the generation of different subsets such as cDC1, cDC2, and pDC using Flt3L in mice, and the generation of bone marrow-derived dendritic cells using GM-CSF. For human dendritic cells, the protocols focus on the culture of CD34(+) cells on OP9 cell layers to generate different subsets, as well as the generation of dendritic cells from peripheral blood monocytes. The article has been peer-reviewed and approved by the co-authors, making it an essential resource for basic and clinical dendritic cell immunologists.
EUROPEAN JOURNAL OF IMMUNOLOGY
(2022)
Article
Cell Biology
Tiago F. Granja, David Kohler, Veronika Leiss, Claudia Eggstein, Bernd Nurnberg, Peter Rosenberger, Sandra Beer-Hammer
Summary: This study investigated the role of extracellular platelet nucleotide signaling in ischemic inflammatory response (IIR) and identified a cybernetic circle, including feedback loops, in the regulation of platelet function in IIR. The study confirmed the presence of different components and feedback loops in the cybernetic system and demonstrated the impact of platelet-neutrophil complex (PNC) formation on blood and inflamed tissue. The integration of extracellular nucleotide signaling, PNC formation, and tissue damage in IIR was described through this study.
Article
Infectious Diseases
Flaminia Mazzone, Viktor E. Simons, Lasse van Geelen, Marian Frank, Attila Mandi, Tibor Kurtan, Klaus Pfeffer, Rainer Kalscheuer
Summary: Toxoplasma gondii is a pathogen that can infect various warm-blooded animals, including humans, causing toxoplasmosis. Current treatments for toxoplasmosis have severe side effects and are not effective in eradicating chronic infection. Therefore, there is an urgent need to develop novel anti-toxoplasma drugs with low toxicity. In this study, eight natural products were isolated from the crude extract of the endophytic fungus Paraboeremia selaginellae obtained from the leaves of the plant Philodendron monstera. Six of these natural products showed antitoxoplasma activity with low or no cytotoxicity in human cell lines. These findings suggest that biphenyl ethers, bioxanthracenes, and 5S,6S-phomalactone from P. selaginellae are potential candidates for novel anti-toxoplasma drugs.
Article
Immunology
Lena-Christin Gruber, Barbara Schneider, Christin Nothnagel, Sandra Beer-Hammer
Summary: The lymphocyte-specific adapter protein SLy1 is essential for thymocyte development and T-cell proliferation. This study found that SLy1(KO) mice have increased levels of p53 in NK cells, but SLy1 and p53 are mechanistically independent for thymocyte development. SLy1 deficiency reduces cell proliferation, resulting in decreased hematologic tumors initiated by p53 deficiency.
EUROPEAN JOURNAL OF IMMUNOLOGY
(2023)
Article
Multidisciplinary Sciences
Veronika Leiss, Roland P. Piekorz, Salvador Castaneda Vega, Christoph Jacoby, Ulrich Floegel, Katja Pexa, Juergen Schrader, Bernd J. Pichler, Sandra Beer-Hammer, Bernd Nuernberg
Summary: This article presents raw and processed data related to the research conducted by Vega et al. (2022). The dataset provides additional insights into the experimental validation of a common carotid artery occlusion (CCAO) model with pretreatment of pertussis toxin (PTX). The data demonstrate the impact of different PTX concentrations on neurological severity measured by Bederson score following CCAO. Furthermore, the data indicate the protective effect of isoflurane on cerebral infarction and neurological deficits, as well as the consequences of PTX pretreatment on reperfusion after occlusion using time-of-flight magnetic resonance angiography.
Meeting Abstract
Immunology
Xiaoli Yang, Lisa Richter, Stefanie Scheu
EUROPEAN JOURNAL OF IMMUNOLOGY
(2021)